川芎嗪注射液、硝苯吡啶对食管癌化疗增效作用的临床研究

The Clinical Study of Synergism of Ligustrazin Combined Nifedipine On Carcinoma of Esophagus With Chemotherapy

目的 观察川芎嗪注射液、硝苯吡啶联合应用对食管癌化疗的增效作用。方法 川芎嗪注射液、硝苯吡啶联合应用于化疗方案中 ,在随机条件下与对照组进行比较。结果 川芎嗪注射液、硝苯吡啶联合应用对化疗确有增效作用 ,治疗组CR +PR4 0 % ,对照组CR +PR2 5% ,两组差异有显著性 (P <0 0 5)。结论 本研究结果提示 :川芎嗪注射液。

Objective To examine the synergism of Ligustrazin Combined Nifedipine on carcinoma of esophagus with chemotherapy.Methods Ligustrazin and Nifedipne combined chemotherapy on carcinoma of esophagus treatment,compared The only chemotherapy group randomly.Results the results showed that the effective rate (CR+PR) of control group were 40% and 25%respectively.Conclusion The results indicted that Ligustrazin combined Nifedipine have synergism on chemotherapy of carcinoma of carcinoma of esophagus.